Reuters logo
4 个月前
BRIEF-Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma
2017年3月27日 / 中午12点16分 / 4 个月前

BRIEF-Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma

1 分钟阅读

March 27 (Reuters) - Delcath Systems Inc

* Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below